AMAG Pharmaceuticals SMA 200
Was ist das SMA 200 von AMAG Pharmaceuticals?
SMA 200 von AMAG Pharmaceuticals, Inc. ist $14 +45.00%
Was ist die Definition von SMA 200?
SMA 200 ist ein durchschnittlicher Aktienkurs der letzten 200 Tage, berechnet als ungewichteter Mittelwert der letzten 200 Schlusskurse.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu AMAG Pharmaceuticals
Was macht AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Unternehmen mit sma 200 ähnlich AMAG Pharmaceuticals
- Takeda Pharmaceutical Co hat SMA 200 von $14 +7.40%
- Delaware Investments Minnesota Municipal Income Fund II Inc hat SMA 200 von $14 -2.92%
- comScore hat SMA 200 von $14 -111.26%
- Carter Bankshares Inc hat SMA 200 von $14 +20.42%
- Eaton Vance Tax-Managed Buy-Write Income Fund hat SMA 200 von $14 +2.80%
- Wereldhave N.V hat SMA 200 von €14 +6.35%
- AMAG Pharmaceuticals hat SMA 200 von $14 +45.00%
- Opera Ltd hat SMA 200 von $14 +3.04%
- CT Real Estate Investment Trust hat SMA 200 von CAD$14 +13.06%
- Ark Restaurants hat SMA 200 von $14 -16.68%
- F.N.B hat SMA 200 von $14 +0.05%
- comScore hat SMA 200 von $14 -111.90%
- comScore hat SMA 200 von $14 -111.90%